Related Experiment Video
Updated: Aug 17, 2026

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
Published on: December 21, 2019
Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues
Lionel Berthoux1, Sarah Sebastian, David M Sayah
1Department of Microbiology, Columbia University College of Physicians and Surgeons, 701 West 168th St., New York, NY 10032, USA.
Abstract:
TRIM5 is a determinant of species-specific differences in susceptibility to infection by retroviruses bearing particular capsids. Human immunodeficiency virus type 1 (HIV-1) infection is blocked by the alpha isoform of macaque TRIM5 (TRIM5alpha(rh)) or by the product of the owl monkey TRIM5-cyclophilin A gene fusion (TRIMCyp). Human TRIM5alpha potently restricts specific strains of murine leukemia virus (N-MLV) but has only a modest effect on HIV-1. The amino termini of TRIM5 orthologues are highly conserved and possess a coiled-coil domain that promotes homomultimerization. Here we show that heterologous expression of TRIM5alpha(rh) or TRIMCyp in human cells interferes with the anti-N-MLV activity of endogenous human TRIM5alpha (TRIM5alpha(hu)). Deletion of the cyclophilin domain from TRIMCyp has no effect on heteromultimerization or colocalization with TRIM5alpha(hu) but prevents interference with anti-N-MLV activity. These data demonstrate that TRIM5 orthologues form heteromultimers and indicate that C-terminal extensions alter virus recognition by multimers of these proteins.
Insights
The TRIM5 protein family influences retroviral infection susceptibility. Heterologous TRIM5 proteins form complexes, altering antiviral activity and virus recognition, particularly impacting murine leukemia virus restriction.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- TRIM5 proteins determine species-specific retroviral infection susceptibility.
- Human TRIM5alpha (TRIM5alpha(hu)) restricts murine leukemia virus (N-MLV) but has limited effect on HIV-1.
- Macaque TRIM5alpha (TRIM5alpha(rh)) and owl monkey TRIM5-cyclophilin A (TRIMCyp) restrict HIV-1.
Purpose of the Study:
- To investigate the functional consequences of TRIM5 orthologue interactions.
- To determine if TRIM5 proteins from different species can form heteromultimers.
- To understand how C-terminal domains influence TRIM5 antiviral activity.
Main Methods:
- Heterologous expression of TRIM5alpha(rh) and TRIMCyp in human cells.
- Assessing the anti-N-MLV activity of endogenous TRIM5alpha(hu) in the presence of heterologous TRIM5 proteins.
- Deletion mutagenesis of the cyclophilin domain in TRIMCyp.
- Analysis of heteromultimerization and colocalization using microscopy.
Main Results:
- Heterologous expression of TRIM5alpha(rh) or TRIMCyp interfered with endogenous TRIM5alpha(hu)'s anti-N-MLV activity.
- Deletion of the cyclophilin domain from TRIMCyp abolished interference with TRIM5alpha(hu) activity.
- TRIM5 orthologues were shown to form heteromultimers and colocalize within cells.
- The cyclophilin domain is crucial for TRIM5-mediated interference but not for heteromultimerization.
Conclusions:
- TRIM5 orthologues can form functional heteromultimers.
- C-terminal domains of TRIM5 proteins modulate the antiviral specificity of these heteromultimers.
- These findings provide insights into the molecular mechanisms of TRIM5-mediated retroviral restriction.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
Retroviruses
Antiviral Nucleoside Inhibitors
Inhibitors Of Virion Release
Non-LTR Retrotransposons

